Digital Therapeutic Alliance member company leaders Pierre Leurent, CEO, Voluntis, Anand Iyer, Chief Strategy Officer, WellDoc, and Vincent Hennemand, VP of Strategy, Corporate & BD, Akili Interactive, will present at the Frontiers Health Summit on November 17 in Berlin, Germany.
Session — Software as a drug: the dawn of Digital Therapies [Keynote and Panel]
Date — Friday, November 17, 2017 2:15pm – 3:15pm
Description — More than 150 companies are already working on digital therapeutics, and an increasing number of these are starting to show significant clinical evidence. In addition, several pharma companies have started investing in digital therapeutics companies, and are partnering to distribute digital therapeutics through their sales channels. This is a strong indication that digital therapeutics will be the “3rd wave of medicine”. Our panel will discuss the resulting industry transformation, the opportunities for healthcare providers and the pharma industry, and what efforts are underway to define new protocols of care and measures of clinical effectiveness.
For more information about the conference, visit www.frontiershealth.co.
The Digital Therapeutics Alliance is proud to participate in the Digital Therapeutics and Digital Medicine Summit to be held in San Jose, CA on Feb 27-28, 2018.
With healthcare becoming more expensive and smart devices more prevalent, digital medicine and digital therapeutics are seeking to improve patients’ lives through validated digital approaches. At this crucial point of rapid adoption, the Digital Therapeutics and Digital Medicine Summit will provide the first industry-dedicated forum to advance this new generation of healthcare.
The Digital Therapeutics and Digital Medicine Summit will serve digital therapeutic & digital medicine companies, pharma and investors who are developing digital solutions for patients in need. Specifically designed for those looking to drive forward this new treatment paradigm, the summit will address the leading scientific, tech and commercial challenges in this rapidly emerging field.
An exec-level gathering for the pioneers and future players in the industry, the Digital Therapeutics and Digital Medicine Summit will aid in defining the foundations of the field, as well as its future direction. Promoting openness and collaboration, the summit will yield genuine insights, idea sharing and investment conversations to capitalize on the potential of this digital revolution.
The Digital Therapeutics and Digital Medicine Summit will bring together the key stakeholders in the industry to connect, share knowledge and define the future of the field.
To learn more, visit: https://digitaltxsummit.com/